Crossmark

Efficacy of androgen receptor signaling inhibitors in combination with androgen deprivation therapy for castration-sensitive metastatic prostate cancer: a retrospective analysis in a Japanese cohort

Crossref DOI link: https://doi.org/10.1007/s10147-024-02670-5

Published Online: 2024-12-18

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Taga, Minekatsu

Sasaki, Takeshi

Higashi, Shinichiro

Kimura, Shoichi

Sawada, Atsuro

Tsuchiyama, Katsuki

Inoue, Takahiro

Kamoto, Toshiyuki

Terada, Naoki https://orcid.org/0009-0005-1082-6089
Funding

Funding for this research was provided by:

University of Fukui
License Information

Text and Data Mining valid from 2024-12-18

Version of Record valid from 2024-12-18
More Information

Article History

Received: 12 June 2024

Accepted: 24 November 2024

First Online: 18 December 2024

Declarations

:

: Toshiyuki Kamoto received honoraria from Janssen, Takeda, Astellas, AstraZeneca, and Sanofi, and research funding from Janssen, MSD, Bayer and AstraZeneca. Takahiro Inoue received honoraria from Janssen, Takeda, Astellas, AstraZeneca, Sanofi and Bayer. Naoki Terada received honoraria from Janssen, Takeda, Astellas, AstraZeneca, Sanofi, and Bayer. Other authors had no conflict of interest to declare.

Document is current

Any future updates will be listed below